In real-world settings multiple factors contribute to non-persistence, including adverse effects, high cost-sharing and ...

GLP-1 RAs are being recommended on social media, raising questions about who can see the content and what the effects might ...

Brands like Kourtney Kardashian's Lemme are claiming to provide the same benefits as GLP-1 medications like Ozempic, Wegovy, ...

The new Lemme GLP-1 Daily Capsules are being called an "Ozempic alternative." But do they really work — and if so, at what ...

People with type 2 diabetes and obesity who develop kidney disease may benefit more from bariatric surgery than from GLP-1 ...

In an interview with Peers & Perspectives in Oncology, Sherry Shen, MD, discusses the GLP-1 agonists analyzed for weight ...

With 890 million people affected globally and 42% of American adults classified as obese, the allure of a "miracle" weight ...

Research shows patients taking weight-loss drugs like Ozempic and Wegovy are more likely to have food left in the stomach or ...

While this class of drugs becomes ever more prevalent, and the wide-ranging positive health outcomes become better known, ...

(HealthDay News) — Use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is associated with the risk for retained gastric contents and inadequate bowel preparation during endoscopic procedures, ...

Recent research easing suicidality concerns about GLP-1s and suggesting potential psychiatric benefit has led to a call for ...

Still, Dasgupta pointed out that GLP-1 drugs “can still help control diabetes ... One hormone that I can give an example of is a hormone called ghrelin, and ghrelin stimulates hunger.